(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 29.30%-488.93K | -1.32%-800.4K | -237.99%-1.92M | 50.94%-313.82K | 36.28%-123.21K | -171.07%-691.59K | -11.60%-789.97K | -141.84%-567.65K | -681.14%-639.62K | -116.72%-193.35K |
Net income from continuing operations | -16,266.04%-1.28M | -6.25%-1.4M | -1,093.62%-16.94M | -1,793.48%-15.07M | -421.80%-562.53K | -99.02%7.94K | 18.03%-1.32M | 52.11%-1.42M | 78.00%-795.64K | -90.81%174.81K |
Operating gains losses | ---- | ---- | -30.01%-1.28M | --0 | ---769.44K | --22.24K | ---536.9K | ---987.7K | ---- | ---- |
Depreciation and amortization | -36.86%308.45K | -36.81%297.16K | 15.82%2M | 8.28%512.73K | -0.86%525.55K | 52.41%488.53K | 17.51%470.27K | 0.94%1.72M | 10.36%473.52K | 23.84%530.11K |
Asset impairment expenditure | ---- | ---- | --13.14M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Unrealized gains and losses of investment securities | -112.28%-3.8K | 12.90%16.68K | --38.9K | ---12.76K | --38.67K | ---1.79K | --14.78K | --0 | --0 | --0 |
Remuneration paid in stock | --0 | --0 | 1,265.04%258.74K | --0 | --11.05K | --0 | 1,206.77%247.7K | -98.55%18.96K | --0 | --0 |
Other non cashItems | -64.85%41.42K | 658.07%193.19K | 548.22%466.5K | -153.68%-21.09K | 190.26%344.26K | 18.46%117.84K | 113.75%25.49K | -90.61%71.97K | -68.30%39.28K | -38.56%118.6K |
Change In working capital | 130.84%411.65K | -70.71%93.22K | 627.10%400.99K | 81.82%1.13M | 129.65%289.22K | -498.37%-1.33M | -49.73%318.24K | -87.85%55.15K | -65.73%620.54K | 28.49%-975.42K |
-Change in receivables | 86.78%-109.4K | 174.31%436.03K | -45.39%309.6K | 217.72%1.28M | -1,791.03%-301.3K | -34.70%-827.7K | -79.99%158.96K | 143.46%566.93K | 278.65%402.76K | 98.47%-15.93K |
-Change in inventory | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---661.53K |
-Change in prepaid assets | ---- | ---- | 50.43%-299.19K | ---- | ---- | ---- | ---- | ---603.61K | ---- | ---- |
-Change in payables and accrued expense | 1,098.23%521.46K | -1,130.97%-343.22K | -110.32%-84.45K | -131.88%-282.49K | 140.69%121.23K | -88.88%43.52K | 120.62%33.29K | -53.47%818.19K | -55.27%886.22K | -330.66%-297.95K |
-Change in other working capital | ---- | -99.68%409 | 165.40%475.03K | ---- | ---- | ---550.57K | --125.99K | ---726.36K | ---- | ---- |
Tax refund paid | 338.07%36.78K | 135.71%3K | --0 | --0 | --0 | --8.4K | -122.67%-8.4K | -135.85%-31.07K | -81.91%10.38K | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 29.30%-488.93K | -1.32%-800.4K | -237.99%-1.92M | 50.94%-313.82K | 36.28%-123.21K | -171.07%-691.59K | -11.60%-789.97K | -141.84%-567.65K | -681.14%-639.62K | -116.72%-193.35K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 11.37%-268.79K | 0 | 419.89%1.55M | -125.24%-121.28K | 296.38%883.43K | -48.84%-303.26K | 450.36%1.09M | 88.62%-484.16K | 112.36%480.51K | -1,246.55%-449.85K |
Net PPE purchase and sale | 11.19%-268.79K | --0 | -32.30%-1.62M | 52.95%-121.28K | -243.30%-1.54M | -48.54%-302.66K | 212.82%350.96K | 74.18%-1.22M | 94.10%-257.79K | -1,246.55%-449.85K |
Net other investing changes | ---- | ---- | 328.83%3.17M | --0 | --2.43M | ---600 | --738.9K | 98.71%738.3K | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 11.37%-268.79K | --0 | 419.89%1.55M | -125.24%-121.28K | 296.38%883.43K | -48.84%-303.26K | 450.36%1.09M | 88.62%-484.16K | 112.36%480.51K | -1,246.55%-449.85K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -34.31%525.12K | 156.63%244.06K | 17.36%-119.43K | -139.10%-212.61K | -11.02%-275.25K | 666.65%799.41K | -44.01%-430.98K | -102.95%-144.51K | 48.07%543.77K | -106.37%-247.93K |
Net issuance payments of debt | -35.65%525.12K | 156.63%244.06K | 89.29%-102.8K | 21.65%-212.61K | -11.02%-275.25K | 678.44%816.04K | -44.01%-430.98K | -18.39%-959.63K | 40.66%-271.35K | 73.25%-247.93K |
Net common stock issuance | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -85.30%845.62K | ---- | ---- |
Net other financing activities | ---- | ---- | 45.48%-16.63K | --0 | --0 | ---- | ---- | 32.54%-30.5K | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -34.31%525.12K | 156.63%244.06K | 17.36%-119.43K | -139.10%-212.61K | -11.02%-275.25K | 666.65%799.41K | -44.01%-430.98K | -102.95%-144.51K | 48.07%543.77K | -106.42%-247.93K |
Net cash flow | ||||||||||
Beginning cash position | -68.38%247.1K | -9.08%817.38K | -59.79%899.04K | 114.92%1.04M | -61.59%588K | -11.65%781.36K | -59.79%899.04K | 785.74%2.24M | -91.29%486K | 177.32%1.53M |
Current changes in cash | -19.01%-232.59K | -324.38%-556.34K | 59.10%-489.27K | -268.38%-647.7K | 154.42%484.97K | -131.10%-195.44K | 90.05%-131.1K | -159.81%-1.2M | 111.28%384.67K | -117.76%-891.13K |
Effect of exchange rate changes | -181.04%-1.68K | -203.96%-13.95K | 390.40%407.61K | 1,382.38%420.58K | 81.47%-28.47K | -88.48%2.08K | 140.51%13.41K | -737.87%-140.36K | -37.96%28.37K | ---153.65K |
End cash Position | -97.82%12.82K | -68.38%247.1K | -9.08%817.38K | -9.08%817.38K | 114.92%1.04M | -61.59%588K | -11.65%781.36K | -59.79%899.04K | -59.79%899.04K | -91.27%486K |
Free cash from | 23.79%-757.72K | 32.05%-800.4K | -97.52%-3.54M | 51.52%-435.1K | -44.38%-928.63K | -229.22%-994.25K | -15.60%-1.18M | 46.99%-1.79M | 78.91%-897.41K | -157.27%-643.21K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data